Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial / Metra, Marco; Jankowska, Ewa A; Pagnesi, Matteo; Anker, Stefan D; Butler, Javed; Dorigotti, Fabio; Fabien, Vincent; Filippatos, Gerasimos; Kirwan, Bridget-Anne; Macdougall, Iain C; Rosano, Giuseppe; Ruschitzka, Frank; Tomasoni, Daniela; Van Der Meer, Peter; Ponikowski, Piotr. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - (2022). [10.1002/ejhf.2630]
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial
Metra, Marco;Pagnesi, Matteo;
2022-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
